CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising incidence of target diseases as well as blood disorders
4.1.2. Increasing corporate & government funding for cell-based research
4.1.3. Development of enhanced informatics solutions & improved image analysis
instruments
4.1.4. Increasing use of high throughput flow cytometry and automated haematology
analysers
4.2. Market Restraints & Challenges
4.2.1. The high cost of advanced cell counting systems
4.2.2. Reluctance among researchers
4.2.3. Product recalls of haematology analysers
4.2.4. Lack of skilled professionals in clinical laboratories
4.2.5. Lack of proper infrastructure in emerging and low-income countries
4.3. Market Opportunities
4.3.1. Increasing focus on Stem cell research and emerging markets
CHAPTER 5. GLOBAL CELL COUNTING MARKET – BY PRODUCT
5.1. Instruments
5.1.1. Spectrophotometers
5.1.1.1. Single-Mode Readers
5.1.1.2. Multi-Mode Readers
5.1.2. Haematology Analyzers
5.1.2.1. Fully Automated Analyzers
5.1.2.2. Semi-Automated Analyzers
5.1.3. Flow Cytometers
5.1.4. Cell Counters
5.1.4.1. Automated Cell Counters
5.1.4.2. Hemocytometers/Manual Cell Counters
5.2. Consumables
5.2.1. Assay Kits
5.2.2. Microplates
5.2.3. Accessories
5.2.4. Media, Sera, & Reagents
5.2.5. Others
CHAPTER 6. GLOBAL CELL COUNTING MARKET – BY APPLICATION
6.1. Research Applications
6.2. Clinical & Diagnostics
6.3. Industrial
CHAPTER 7. GLOBAL CELL COUNTING MARKET – BY END USER
7.1. Hospitals
7.2. Pharmaceutical & Biotechnology Companies
7.3. Research Institutes
7.4. Clinical Laboratories
7.5. Others
CHAPTER 8. GLOBAL CELL COUNTING MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL CELL COUNTING MARKET - COMPANY PROFILES
9.1. GE Healthcare
9.2. Thermo Fisher Scientific
9.3. Merck KGaA
9.4. Beckton, Dickson and Company
9.5. Biotek Instruments Inc.
9.6. Bio-Rad Laboratories, Inc.
9.7. Agilent Technologies, Inc.
9.8. Danaher Corporation
9.9. Tecan Group Ltd.
9.10. PerkinElmer Inc.
9.11. Siemens Healthnieers
9.12. F-Hoffmann La Roche AG
9.13. Abbott Laboratories
9.14. Sysmex Corporation
9.15. Horiba
CHAPTER 10. GLOBAL CELL COUNTING MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
